ebastine has been researched along with Irritable Bowel Syndrome in 3 studies
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ebastine, an antagonist of HRH1, reduced visceral hypersensitivity, symptoms, and abdominal pain in patients with IBS." | 5.22 | Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome. ( Alpizar, YA; Augustijns, P; Balemans, D; Belmans, A; Boeckxstaens, GE; Bulmer, DC; Carmeliet, P; Cibert-Goton, V; Cirillo, C; Dooley, J; Ghesquière, B; Hellings, PW; Kortekaas, I; Liston, A; Mols, R; Nasser, Y; Peetermans, WE; Rutgeerts, P; Talavera, K; Valdez-Morales, EE; Van der Merwe, S; Van Veldhoven, PP; Van Wanrooy, S; Vanbrabant, W; Vanden Berghe, P; Vanner, S; Vermeire, S; Wouters, MM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanisor, OI | 1 |
| van Diest, SA | 1 |
| Yu, Z | 1 |
| Welting, O | 1 |
| Bekkali, N | 1 |
| Shi, J | 1 |
| de Jonge, WJ | 1 |
| Boeckxstaens, GE | 2 |
| van den Wijngaard, RM | 1 |
| Wouters, MM | 1 |
| Balemans, D | 1 |
| Van Wanrooy, S | 1 |
| Dooley, J | 1 |
| Cibert-Goton, V | 1 |
| Alpizar, YA | 1 |
| Valdez-Morales, EE | 1 |
| Nasser, Y | 1 |
| Van Veldhoven, PP | 1 |
| Vanbrabant, W | 1 |
| Van der Merwe, S | 1 |
| Mols, R | 1 |
| Ghesquière, B | 1 |
| Cirillo, C | 1 |
| Kortekaas, I | 1 |
| Carmeliet, P | 1 |
| Peetermans, WE | 1 |
| Vermeire, S | 1 |
| Rutgeerts, P | 1 |
| Augustijns, P | 1 |
| Hellings, PW | 1 |
| Belmans, A | 1 |
| Vanner, S | 1 |
| Bulmer, DC | 1 |
| Talavera, K | 1 |
| Vanden Berghe, P | 1 |
| Liston, A | 1 |
| Camilleri, M | 1 |
| Boeckxstaens, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IBS Treatment With H1-receptor Antagonists[NCT01144832] | Phase 4 | 55 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ebastine and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Dietary and pharmacological treatment of abdominal pain in IBS.
Topics: Abdominal Pain; Anti-Infective Agents; Antidepressive Agents; Butyrophenones; Dipeptides; GABA Agent | 2017 |
1 trial available for ebastine and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Analgesics; Belgium; Biopsy; Butyrophenones; Calcium Signal | 2016 |
1 other study available for ebastine and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Stress-induced visceral hypersensitivity in maternally separated rats can be reversed by peripherally restricted histamine-1-receptor antagonists.
Topics: Animals; Blotting, Western; Butyrophenones; Dose-Response Relationship, Drug; Histamine H1 Antagonis | 2013 |